SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-017089
Filing Date
2019-01-25
Accepted
2019-01-25 16:16:02
Documents
6
Effectiveness Date
2019-01-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A d667531ddefa14a.htm DEFA14A 41523
2 GRAPHIC g667531dsp03.jpg GRAPHIC 1337
3 GRAPHIC g667531dsp04a.jpg GRAPHIC 2491
4 GRAPHIC g667531dsp04b.jpg GRAPHIC 1317
5 GRAPHIC g667531dsp05.jpg GRAPHIC 1288
6 GRAPHIC g667531dsp06.jpg GRAPHIC 1293
  Complete submission text file 0001193125-19-017089.txt   54217
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-38042 | Film No.: 19542721
SIC: 2834 Pharmaceutical Preparations